Surveillance of epilepsy and prevention of epilepsy and its sequelae: Lessons from the Institute of Medicine report

Current Opinion in Neurology

Volumn 26, Issue 2, 2013, Pages 168-173

  Hesdorffer, Dale C ^a   Begley, Charles E ^b  

^a Vagelos College of Physicians and Surgeons   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

IOM report; prevention; surveillance

Indexed keywords

CEREBRAL PALSY; CEREBROVASCULAR ACCIDENT; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; ELECTRONIC DATA INTERCHANGE; EPILEPSY; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; MEDICAID; MEDICAL CARE; MEDICARE; MENTAL DISEASE; MORBIDITY; MORTALITY; NEUROCYSTICERCOSIS; PREVALENCE; PRIMARY PREVENTION; REMISSION; REVIEW; SOCIAL STATUS; SUICIDE; SYSTEMATIC REVIEW (TOPIC); TRAUMATIC BRAIN INJURY; VALIDATION STUDY;

EPILEPSY; HUMANS; INSTITUTE OF MEDICINE (U.S.); UNITED STATES;

EID: 84874938945     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32835ef2c7     Document Type: Review

References (43)

1. German RR. Undated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR 2001; 50:1-35.
2. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993; 34:453-458.
3. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1984. Epilepsia 1991; 32:429-445.
4. Brooks DR, Avetisyan R, Jarrett KM, et al. Validation of self-reported epilepsy for purposes of community surveillance. Epilepsy Behav 2012; 23:57-63.
5. Kobau R, Zahran H, Grant D, et al. Prevalence of active epilepsy and healthrelated quality of life among adults with self-reported epilepsy in California: California Health Interview Survey. Epilepsia 2007; 48:1904-1913. (Pubitemid 47537441)
6. Kobau R, Luo YH, Zack MM, et al. Epilepsy in adults and access to care-United States, 1912. MMWR 2012; 61:909-913.
7. Thurman DJ, Beghi E, Begley CE, et al., ILAE Commission on Epidemiology. Standards for epidemiological studies and surveillance of epilepsy. Epilepsia 2011; 52 (Suppl 7):2-26.
8. Szaflarski M, Szaflarski JP, Privitera MD, et al. Racial/ethnic disparities in the treatment of epilepsy: what do we know? What do we need to know? Epilepsy Behav 2006; 9:243-264. (Pubitemid 44375498)
9. IOM (Institute of Medicine). Access to healthcare in America. Washington, DC: National Academies Press; 1993.
10. Begley CE, Basu R, Lairson D, et al. Socio-economic status, healthcare use and outcomes: persistence of disparities over time. Epilepsia 2011; 52:957-964.
11. Farhidvash F, Singh P, Abou-Khalil B, Arain A. Patients visiting the emergency room for seizures: Insurance status and clinic follow-up. Seizure 2009; 18:644-647.
12. Ouellette E, Chong J, Drake K, Labiner D. Emergency department care of seizure patients: demographic trends in southern. Arizona Epilepsy Behav 2011; 21:382-386.
13. Kelvin EA, Hesdorffer DC, Bagiella E, Andrews H, et al. Prevalence of selfreported epilepsy in a multiracial and multiethnic community in New York City. Epilepsy Res 2007; 77:141-150. (Pubitemid 350153631)
14. Bisgaier J, Rhodes KV. Auditing access to specialty care for children with public insurance. N Engl J Med 2011; 364:2324-2333.
15. Halpern MT, Renaud JM, Vickery BG. Impact of insurance status on access to care and out-of-pocket costs for U.S. individuals with epilepsy. Epilepsy Behav 2011; 22:483-489.
16. Bautista RE, Graham C, Mukardamwala S. Health disparities in medication adherence between African-Americans and Caucasians with epilepsy. Epilepsy Behav 2011; 22:495-496.
17. McClelland S, Hongfei G, Okuyemi KS. Racial disparities in the surgical management of intractable temporal lobe epilepsy in the United States. Arch Neurol 2010; 67:577-583.
18. Polsky D, Weiner J, Bale JF Jr, et al. Specialty care by child neurologists: a workforce analysis. Neurology 2005; 64:942-948. (Pubitemid 40388440)
19. Yoon D, Frick KD, Carr DA, Austin JK. Economic impact of epilepsy in the United States. Epilepsia 2009; 50:2186-2191.
20. Ivanova JI, Birnbaum HG, Kidolezi Y, et al. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Epilepsia 2010; 51:838-844.
21. Chen S-Y, Wu N, Boulanger L, Sacco P. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States. J Med Econ 2013; 16:1-9.
22. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000; 41:342-351. (Pubitemid 30134292)
23. Halpern M, Rentz A, Murray M. Cost of illness of epilepsy in the US: comparison of patient-based and population-based estimates. Neuroepidemiology 2000; 19:87-99. (Pubitemid 30111737)
24. Pugliatti M, Beghi E, Forsgren L, et al. Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 2007; 48:2224-2233. (Pubitemid 350243405)
25. Strzelezyk A, Reese JP, Dodel R, Hamer HM. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008; 26:463-476. (Pubitemid 351704857)
26. Beghi E, Atzeni L, Garattini L. Economic analysis of newer antiepileptic drugs. CNS Drugs 2008; 22:861-875.
27. AHRQ. Effectiveness and safety of antiepileptic medications in patients with epilepsy. Comparative Effectiveness Rev 2011; 40:1-24. http://effective healthcare.ahrq.gov/ehc/products/159/896/CER40-Epilepsy-executive summary-20111231.pdf. [Accessed 22 December 2012]
28. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999; 91:593-600. (Pubitemid 30133456)
29. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of posttraumatic seizures. N Engl J Med 1990; 323:497-502. (Pubitemid 20260049)
30. Coronado VG, Xu L, Basavaraju SV, et al. Surveillance for traumatic brain injury-related deaths-United States, 1997-2007. MMWR Summ 2011; 60:1-32.
31. Institute of Medicine. Epilepsy across the spectrum: promoting heath and understanding. Washington, DC: The National Academies Press; 2012. p. 119.
32. Schantz, P. Neurocysticercosis (Taenia solium infection): feasibility and strategy of eradication. 2002. ftp://ftp.cdc.gov/pub/infectious-diseases/iceid/ 2002/pdf/schantz.pdf. [Accessed 19 December 2012]
33. World Health Organization, Fifty-fifth world health assembly. Control of neurocysticercosis. A55/23, 5 April 2012. http://apps.who.int/gb/archive/pdf- files/WHA55/ea5523.pdf. [Accessed 20 December 2012]
34. Cockerell OC, Johnson AL, Sander JW, et al. Mortality from epilepsy: results from a prospective population-based study. Lancet 1994; 344:918-921. (Pubitemid 24295878)
35. Rafnsson VE, Olafsson E, Hauser WA, Gudmundsson G. Cause-specific mortality in adults with unprovoked seizures. A population-based incidence cohort study. Neuroepidemiology 2001; 20:232-236. (Pubitemid 34701951)
36. Klenerman P, Sander JW, Shorvon SD. Mortality in patients with epilepsy: a study of patients in long term residential care. J Neurol Neurosurg Psychiatry 1993; 56:149-152. (Pubitemid 23075407)
37. Tomson T, Beghi E, Sundqvist A, Johannessen SI. Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res 2004; 60:1-16. (Pubitemid 38981756)
38. Ryvlin P, Cucherat M, Rheims S. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol 2011; 11:961-968.
39. Hesdorffer DC, Tomson T, Benn EKT, et al., for the ILAE Commission on Epidemiology, Subcommission on Mortality. Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia 2012; 53:249-252.
40. Lamberts RJ, Thijs RD, Laffan A, et al. Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia 2012; 53:253-257.
41. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170:205-228. (Pubitemid 27117683)
42. Hesdorffer DC, Ishihara L, Mynepalli L, et al. Epilepsy, suicidality and psychiatric disorders: a bidirectional association. Ann Neurol 2012; 72:184-191.
43. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA 2005; 294:2064-2074. (Pubitemid 41539940)